Literature DB >> 29390912

Carbon- versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors?

Claudiu T Supuran1.   

Abstract

A set of compounds incorporating carbon-based zinc-binding groups (ZBGs), of the type PhX (X = COOH, CONH2, CONHNH2, CONHOH, CONHOMe), and the corresponding derivatives with sulphur(VI)-based ZBGs (X = SO3H, SO2NH2, SO2NHNH2, SO2NHOH, SO2NHOMe) were tested as inhibitors of all mammalian isoforms of carbonic anhydrase (CA, EC 4.2.1.1), CA I-XV. Three factors connected with the ZBG influenced the efficacy as CA inhibitor (CAI) of the investigated compounds: (i) the pKa of the ZBG; (ii) its geometry (tetrahedral, i.e. sulphur-based, versus trigonal, i.e. carbon-based ZBGs), and (iii) orientation of the organic scaffold induced by the nature of the ZBG. Benzenesulphonamide was the best inhibitor of all isoforms, but other ZBGs led to interesting inhibition profiles, although with an efficacy generally reduced when compared to the sulphonamide. The nature of the ZBG also influenced the CA inhibition mechanism. Most of these derivatives were zinc binders, but some of them (sulfonates, carboxylates) may interact with the enzyme by anchoring to the zinc-coordinated water molecule or by other inhibition mechanisms (occlusion of the active site entrance, out of the active site binding, etc.). Exploring structurally diverse ZBGs may lead to interesting new developments in the field of CAIs.

Entities:  

Keywords:  Carbonic anhydrase; anchoring to zinc-coordinated water; carboxylate; hydroxamate; inhibition mechanism; inhibitors; sulphonamide; zinc binder

Mesh:

Substances:

Year:  2018        PMID: 29390912      PMCID: PMC6009921          DOI: 10.1080/14756366.2018.1428572

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  10 in total

1.  Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of N-substituted benzenesulfonamides to human isoform II.

Authors:  Anna Di Fiore; Alfonso Maresca; Vincenzo Alterio; Claudiu T Supuran; Giuseppina De Simone
Journal:  Chem Commun (Camb)       Date:  2011-09-26       Impact factor: 6.222

Review 2.  Carbonic anhydrases: novel therapeutic applications for inhibitors and activators.

Authors:  Claudiu T Supuran
Journal:  Nat Rev Drug Discov       Date:  2008-02       Impact factor: 84.694

Review 3.  Acetazolamide for the treatment of idiopathic intracranial hypertension.

Authors:  Claudiu T Supuran
Journal:  Expert Rev Neurother       Date:  2015-07-07       Impact factor: 4.618

4.  Thermodynamic optimisation in drug discovery: a case study using carbonic anhydrase inhibitors.

Authors:  Andrew D Scott; Chris Phillips; Alexander Alex; Maria Flocco; Andrew Bent; Amy Randall; Ronan O'Brien; Luminita Damian; Lyn H Jones
Journal:  ChemMedChem       Date:  2009-12       Impact factor: 3.466

Review 5.  Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 - 2013).

Authors:  Fabrizio Carta; Claudiu T Supuran
Journal:  Expert Opin Ther Pat       Date:  2013-03-14       Impact factor: 6.674

Review 6.  Interfering with pH regulation in tumours as a therapeutic strategy.

Authors:  Dario Neri; Claudiu T Supuran
Journal:  Nat Rev Drug Discov       Date:  2011-09-16       Impact factor: 84.694

7.  The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C.

Authors:  R G Khalifah
Journal:  J Biol Chem       Date:  1971-04-25       Impact factor: 5.157

8.  "Seriously Sweet": Acesulfame K Exhibits Selective Inhibition Using Alternative Binding Modes in Carbonic Anhydrase Isoforms.

Authors:  Akilah B Murray; Carrie L Lomelino; Claudiu T Supuran; Robert McKenna
Journal:  J Med Chem       Date:  2018-01-05       Impact factor: 7.446

9.  Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors.

Authors:  Anna Di Fiore; Alfonso Maresca; Claudiu T Supuran; Giuseppina De Simone
Journal:  Chem Commun (Camb)       Date:  2012-07-27       Impact factor: 6.222

10.  Xanthates and trithiocarbonates strongly inhibit carbonic anhydrases and show antiglaucoma effects in vivo.

Authors:  Fabrizio Carta; Atilla Akdemir; Andrea Scozzafava; Emanuela Masini; Claudiu T Supuran
Journal:  J Med Chem       Date:  2013-05-16       Impact factor: 7.446

  10 in total
  32 in total

1.  Cloning, purification, kinetic and anion inhibition studies of a recombinant β-carbonic anhydrase from the Atlantic salmon parasite platyhelminth Gyrodactylus salaris.

Authors:  Ashok Aspatwar; Harlan Barker; Heidi Aisala; Ksenia Zueva; Marianne Kuuslahti; Martti Tolvanen; Craig R Primmer; Jaakko Lumme; Alessandro Bonardi; Amit Tripathi; Seppo Parkkila; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

2.  Benzamide-4-Sulfonamides Are Effective Human Carbonic Anhydrase I, II, VII, and IX Inhibitors.

Authors:  Morteza Abdoli; Murat Bozdag; Andrea Angeli; Claudiu T Supuran
Journal:  Metabolites       Date:  2018-06-01

3.  New sulfonamides containing organometallic-acylhydrazones: synthesis, characterisation and biological evaluation as inhibitors of human carbonic anhydrases.

Authors:  Yosselin Huentupil; Luis Peña; Néstor Novoa; Emanuela Berrino; Rodrigo Arancibia; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

4.  Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies.

Authors:  Ciro Milite; Giorgio Amendola; Alessio Nocentini; Silvia Bua; Alessandra Cipriano; Elisabetta Barresi; Alessandra Feoli; Ettore Novellino; Federico Da Settimo; Claudiu T Supuran; Sabrina Castellano; Sandro Cosconati; Sabrina Taliani
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

5.  Synthesis and biological evaluation of novel 3-(quinolin-4-ylamino)benzenesulfonamidesAQ3 as carbonic anhydrase isoforms I and II inhibitors.

Authors:  Mohammad M Al-Sanea; Ahmed Elkamhawy; Sora Paik; Silvia Bua; So Ha Lee; Mohamed A Abdelgawad; Eun Joo Roh; Wagdy M Eldehna; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

6.  A structure-based approach towards the identification of novel antichagasic compounds: Trypanosoma cruzi carbonic anhydrase inhibitors.

Authors:  Manuel A Llanos; María L Sbaraglini; María L Villalba; María D Ruiz; Carolina Carrillo; Catalina Alba Soto; Alan Talevi; Andrea Angeli; Seppo Parkkila; Claudiu T Supuran; Luciana Gavernet
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

7.  Discovery of novel 1,3-diaryltriazene sulfonamides as carbonic anhydrase I, II, VII, and IX inhibitors.

Authors:  Suleyman Akocak; Nabih Lolak; Silvia Bua; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

8.  Synthesis, characterisation, biological evaluation and in silico studies of sulphonamide Schiff bases.

Authors:  Mustafa Durgun; Cüneyt Türkeş; Mesut Işık; Yeliz Demir; Ali Saklı; Ali Kuru; Abdussamat Güzel; Şükrü Beydemir; Suleyman Akocak; Sameh M Osman; Zeid AlOthman; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

9.  Preparation, carbonic anhydrase enzyme inhibition and antioxidant activity of novel 7-amino-3,4-dihydroquinolin-2(1H)-one derivatives incorporating mono or dipeptide moiety.

Authors:  Hasan Küçükbay; Zeynep Gönül; F Zehra Küçükbay; Andrea Angeli; Gianluca Bartolucci; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

Review 10.  Benzothiazole derivatives as anticancer agents.

Authors:  Ali Irfan; Fozia Batool; Syeda Andleeb Zahra Naqvi; Amjad Islam; Sameh M Osman; Alessio Nocentini; Siham A Alissa; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.